Pharmaceuticals company Acutaas Chemicals announced Q2FY26 results Revenue from operations for Q2FY26 grew by 24.1% YoY to Rs 3,062 million. The gross margin for the quarter improved to 55.8% up 1,232 bps YoY. EBITDA for the quarter came at Rs 953 million up 94.8% YoY. EBITDA margin for the quarter was at 31.1% as compared to 19.8% in Q2FY25. PAT for the quarter was Rs 719 million up 91.3% as compared to PAT of Rs 376 million in Q2FY25. The PAT margin for the quarter was at 23.5% up 824 bps YoY. Export for the quarter at 76%; domestic business at 24%. Naresh Patel, Executive Chairman & Managing Director, Acutaas Chemicals, said: “Our focus has always been on building a long-term, sustainable business rather than chasing short-term opportunities. This disciplined approach is now yielding tangible results as we strengthen global partnerships and expand into new growth verticals such as Battery Chemicals and Semiconductors. In Q2FY26, our revenue grew by 24.1% YoY to Rs 3,062 million, driven by strong performance in Advanced Pharmaceutical Intermediates and stable contributions from Specialty Chemicals. We remain confident of delivering around 25% revenue growth for the full year, backed by a resilient business foundation and clear strategic direction” Result PDF
